Intangible Assets, Net (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Intangible Assets, Net (Details) [Line Items] | ||
Indefinite-lived intangible assets acquired | $ 19,000,000 | |
Amortization of intangible assets | 763,000 | $ 1,162,000 |
Asset impairment charges | $ 0 | |
License [Member] | ||
Intangible Assets, Net (Details) [Line Items] | ||
Indefinite-lived intangible assets acquired | $ 19,000,000 | |
Valuation Technique, Discounted Cash Flow [Member] | ||
Intangible Assets, Net (Details) [Line Items] | ||
Percentage of impairment rate | 22.00% | |
Perpetual growth rate | 3.00% | |
Valuation Technique, Discounted Cash Flow [Member] | Minimum [Member] | ||
Intangible Assets, Net (Details) [Line Items] | ||
Perpetual growth rate | 19000.00% | |
Valuation Technique, Discounted Cash Flow [Member] | Maximum [Member] | ||
Intangible Assets, Net (Details) [Line Items] | ||
Perpetual growth rate | 6650.00% | |
Herbal Brands, Inc. [Member] | ||
Intangible Assets, Net (Details) [Line Items] | ||
Finite-lived intangible assets acquired | $ 7,091,000 |
X | ||||||||||
- Definition Impairment Analysis, Perpetual Growth Rate No definition available.
|
X | ||||||||||
- Definition Impairment Analysis, Weighted-average Cost of Capital No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|